AddalaA, AuzanneauM, MillerK, et al.A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care, 2021; 44: 133–140.
2.
AgarwalS, SchechterC, GonzalezJ, LongJA. Racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther, 2021; 23: 306–313.
3.
LaiCW, LipmanTH, WilliSM, HawkesCP. Racial and ethnic disparities in rates of continuous glucose monitor initiation and continued use in children with type 1 diabetes. Diabetes Care, 2021:44: 255–257.
4.
AuzanneauM, RosenbauerJ, MaierW, et al.Heterogeneity of access to diabetes technology depending on area deprivation and demographics between 2016 and 2019 in Germany. J Diabetes Sci Technol, 2021; 15: 1059–1068.
5.
Messer LH & WeinzimerSA.Practical diabetes technology: overcoming barriers in the real world. Diabetes Technol Ther, 2021; 23: S159–S168.
6.
DovcK, Van NameM, Jenko BizjanB, et al.Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): a multinational prospective observational real-world cohort study. Diabetes Obes Metab, 2022; 24: 564–569.
7.
Pleus S FreckmannG, SchauerS, et al.Self-monitoring of blood glucose as an integral part in the management of people with type 2 diabetes mellitus. Diabetes Ther, 2022; 13: 829–846.
8.
ProiettiA, RaggioM, PazM, et al.Six-month glycemic control with a hybrid closed-loop system in type 1 diabetes patients in a Latin American country. Diabetes Technol Ther, 2022; 24: 220–226.
9.
ChoeJ, WonSH, ChoeY, et al.Temporal trends for diabetes management and glycemic control between 2010 and 2019 in Korean children and adolescents with type 1 diabetes. Diabetes Technol Ther, 2022; 24: 201–211.
10.
MariglianoM, EckertAJ, GunessPK, et al.Association of the use of diabetes technology with HbA1c and BMI-SDS in an international cohort of children and adolescents with type 1 diabetes: the SWEET project experience. Pediatr Diabetes, 2021; 22: 120–1128.
11.
GerhardssonP, SchwandtA, WitschM, et al.The SWEET project 10-year benchmarking in 19 countries worldwide is associated with improved HbA1c and increased use of diabetes technology in youth with type 1 diabetes. Diabetes Technol Ther, 2021; 23: 491–499.
12.
DonaghueKC, MarcovecchioML, WadwaRP, et al.ISPAD Clinical Practice Consensus Guidelines 2018: microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes, 2018; 19(Suppl 27): 262–274.
13.
MaffeisC, BirkebaekNH, KonstantinovaM, et al.Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: data from the international SWEET registry. Pediatr Diabetes, 2018; 19: 1211–1220.
14.
SilvaJD, LeporeG, BattelinoT, et al.Real-world performance of the MiniMed 780G System: first report of outcomes from 4120 users. Diabetes Technol Ther, 2022:24: 113–119.
15.
HohendorffJ, GumprechtJ, MysliwiecM, Zozulinska-ZiolkiewiczD, MaleckiMT. Intermittently scanned continuous glucose monitoring data of polish patients from real-life conditions: more scanning and better glycemic control compared to worldwide data. Diabetes Technol Ther, 2021; 23: 577–585.
16.
Beato-VíboraPI, Gallego-GameroF, Ambrojo-LópezA, Gil-PochE, Martín-RomoI, Arroyo-DíezFJ. Rapid improvement in time in range after the implementation of an advanced hybrid closed-loop system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther, 2021; 23: 609–615.
17.
WeinstockRS, Schütz-FuhrmannI, ConnorCG, et al.Type 1 diabetes in older adults: comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries. Diabetes Res Clin Pract, 2016; 122: 28–37.
18.
FosterNC, BeckRW, MillerKM, el al. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016–2018. Diabetes Technol Ther, 2019; 21: 66–72.
19.
MillerKM, BeckRW, FosterNC, MaahsDM. HbA1c levels in type 1 diabetes from early childhood to older adults: a deeper dive into the influence of technology and socioeconomic status on HbA1c in the T1D Exchange Clinic Registry Findings. Diabetes Technol Ther, 2020; 22: 645–650.
20.
MunshiM, SlyneC, DavisD, et al.Use of technology in older adults with type 1 diabetes: clinical characteristics and glycemic metrics. Diabetes Technol Ther, 2022; 24: 1–9.
21.
ToschiE, Atakov-CastilloA, SlyneC, MunshiM. Closed-loop insulin therapy in older adults with type 1 diabetes: real-world data. Diabetes Technol Ther, 2022; 24: 140–142.
22.
KhanMAB, HashimMJ, KingJK, GovenderRD, MustafaH, Al KaabiJ. Epidemiology of type 2 diabetes–global burden of disease and forecasted trends. J Epidemiol Glob Health, 2020; 10: 107–111.
23.
BeckRW, RiddlesworthTD, RuedyK, et al.Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med, 2017; 167: 365–374.
24.
MartensT, BeckRW, BaileyR, et al.Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA, 2021:325: 2262–2272.
25.
CarlsonAL, DanielTD, DeSantisA, et al.Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis. BMJ Open Diabetes Res Care, 2022; 10: e002590.
26.
KarterAJ, ParkerMM, MoffetHH, GilliamLK, DlottR. Continuous Glucose monitor use prevents glycemic deterioration in insulin-treated patients with type 2 diabetes. Diabetes Technol Ther, 2022; 24: 332–337.
27.
MillerE, KerrMSD, RobertsGJ, NabutovskyY, WrightE. Flash CGM associated with event reduction in nonintensive diabetes therapy. Am J Manag Care, 2021; 27: e372–e377.
28.
SherwoodJS, JafriRZ, BalliroCA, et al.Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: a pilot study. J Cyst Fibros, 2020; 19: 159–161.
29.
ScullyKJ, PalaniG, ZhengH, MoheetA, PutmanMS. The effect of Control IQ hybrid closed loop technology on glycemic control in adolescents and adults with cystic fibrosis–related diabetes. Diabetes Technol Ther, 2022; 24: 446–452.
30.
AuzanneauM, LanzingerS, BohnB, et al.Area deprivation and regional disparities in treatment and outcome quality of 29,284 pediatric patients with type 1 diabetes in Germany: a cross-sectional multicenter DPV analysis. Diabetes Care, 2018; 41: 2517–2525.
31.
AuzanneauM, RosenbauerJ, MaierW, et al.Heterogeneity of access to diabetes technology depending on area deprivation and demographics between 2016 and 2019 in Germany. J Diabetes Sci Technol, 2021; 15: 1059–1068.
32.
FallonC, JonesE, OliverN, ReddyM, AvariP. The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes. Diabet Med 2022 June 25: e14906. Online ahead of print.
33.
JohnsonSR, Holmes-WalkerDJ, CheeM, et al.Universal subsidized continuous glucose monitoring funding for young people with type 1 diabetes: uptake and outcomes over 2 years, a population-based study. Diabetes Care, 2022; 45: 391–397.
34.
Hill-BriggsF, AdlerNE, BerkowitzSA, et al.Social determinants of health and diabetes: a scientific review. Diabetes Care, 2020; 44: 258–279.
35.
OdugbesanO, AddalaA, NelsonG, et al.Implicit racial-ethnic and insurance-mediated bias to recommending diabetes technology: insights from T1D Exchange multicenter pediatric and adult diabetes provider cohort. Diabetes Technol Ther, 2022; 24: 619–627.
36.
AddalaA, HanesS, NaranjoD, MaahsDM, HoodKK. Provider implicit bias impacts pediatric type 1 diabetes technology recommendations in the United States: findings from the Gatekeeper Study. J Diabetes Sci Technol, 2021; 15: 1027–1033.
37.
SchmittJ, FogleK, ScottML, IyerP. Improving equitable access to continuous glucose monitors for Alabama's children with type 1 diabetes: a quality improvement project. Diabetes Technol Ther, 2022; 24: 481–491.
38.
EbekozienO, MungmodeA, OdugbesanO, et al.Addressing type 1 diabetes health inequities in the United States: approaches from the T1D Exchange QI Collaborative. J Diabetes, 2022; 14: 79–82.
39.
MencherSR, WeinzimerSA, NallyLM, Van NameM, Nunez-SmithM, SadlerLS. Technology utilization in black adolescents with type 1 diabetes: exploring the decision-making process. Diabetes Technol Ther, 2022; 24: 249–257
40.
TremblayES, RuizJ, DykemanB, MaldonadoM, GarveyK. Hispanic caregivers' experience of pediatric type 1 diabetes: a qualitative study. Pediatr Diabetes, 2021; 22: 1040–1050.
41.
MajidiS, EbekozienO, NoorN, et al.Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative. Clin Diabetes, 2021; 39: 278–283.